Adipotide

Vain tutkimustarkoituksiin. Not for human or veterinary use.

Yleiskatsaus

Adipotide (also written as FTPP, or by its sequence CKGGRAKDC-GG-D(KLAKLAK)2) is a proapoptotic peptidomimetic built for vascular targeting of white adipose tissue. Two functional halves are joined in a single molecule: a homing peptide, CKGGRAKDC, that binds prohibitin displayed on the endothelium of blood vessels feeding white fat, and a proapoptotic domain, D(KLAKLAK)2, that disrupts mitochondrial membranes once it is internalised. The homing sequence was originally isolated through in vivo phage-display screening for peptides that localise to white adipose tissue vasculature, which is what gives the conjugate its tissue selectivity in research models.

The molecule was characterised by researchers at the University of Texas MD Anderson Cancer Center. It is frequently discussed as a conceptual parallel to antibody-drug conjugates: the cytotoxic payload is only delivered where the targeting element has bound, so activity is concentrated at the intended vascular bed rather than distributed systemically. CertaPeptides is a reseller and supplies Adipotide as a research reagent; we do not manufacture, formulate, or select the salt form of this compound.

Research Areas

Published literature has investigated Adipotide primarily as a tool for studying adipose-tissue vascular biology and the metabolic consequences of ablating fat-feeding vasculature. In the foundational mouse work, targeted ablation of adipose vasculature was used to study adipose-tissue remodelling and established prohibitin on adipose endothelium as an addressable target (Kolonin et al., 2004). A later non-human primate study examined tissue selectivity, metabolic parameters and renal markers (Barnhart et al., 2011). These two datasets remain the most cited reference points for researchers modelling vascular-targeting approaches to adipose tissue. Typical research questions include how selective prohibitin targeting is across different vascular beds, how model organisms respond to adipose vascular ablation, and how the conjugate format governs where apoptosis is triggered.

Specifications

Quality & Verification

The class-level specification on record is ≥98%. No independent report is on record for this product yet; independent reports on selected lots are searchable by batch or report code at certapeptides.com/verify. We make no in-house testing claim and do not test every batch. EU-based handling under CERTALAB S.R.L.

Vain tutkimustarkoituksiin. Ei ihmisravinnoksi.